Law firm Mills & Reeve has expanded its nationally-recognised healthcare team with the appointment of Neil Ward.
Neil, formerly a partner at Browne Jacobson for ten years, specialises in all areas of healthcare law. His particular areas of expertise relate to inquests and high-profile serious medical treatment cases heard in the Court of Protection.
Neil will be based in the Birmingham office where he will help to grow the healthcare law work from both public and independent sector health and care sector clients.
Jill Mason, partner and head of Mills & Reeve’s health and care sector, said: “We are excited to welcome Neil to our national healthcare law team and to the wider health and care sector here at Mills & Reeve. Neil has a wealth of experience in managing and growing a team and has a wide network of contacts in the Midlands. Working alongside our existing team, his contribution will help us to strengthen our leading position in the region.”
Neil said: “I am delighted to have the opportunity to work with the team at Mills & Reeve, who have a well-deserved reputation as being one of the leading healthcare practices in the country. The firm has an excellent client base and I look forward to being able to support the work that the firm does in delivering a really high quality service to them.”
Law firm offers free workshops for companies
Mills & Reeve shakes up market
Award-winning education and real estate expert will lead the team
Clarke Willmott bolsters commercial property team
Additional staff appointed and new regional office launched
Appointment boosts strong commercial property division
Director and Solicitor, Kang & Co Solicitors
Appointments made as practice prepares for further growth
Law firm advises on sale to industry giant
Law firm appoints commercial property expert
Legal community hosts virtual awards ceremony
New non-executive director will help to deliver strategic vision
Law firm named as the best to work for in the Black Country
Future-planning advice will continue during Coronavirus crisis
Firms warned that not all staff will want the vaccine